Engineers Gate Manager LP Landec Corp \Ca\ Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	N/A	2,615 Added 18.02%	17,127 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-3,394 Reduced 18.95%	14,512 $0
Q2 2023 Aug 14, 2023	BUY	N/A	17,906 New	17,906 $0
Q3 2021 Nov 15, 2021	SELL	$9.22 - $12.44 $137,617 - $185,679	-14,926 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.91 - $12.78 $118,810 - $153,219	-11,989 Reduced 44.54%	14,926 $168,000
Q1 2021 May 17, 2021	SELL	$10.44 - $12.22 $57,388 - $67,173	-5,497 Reduced 16.96%	26,915 $285,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $11.77 $12,992 - $16,442	1,397 Added 4.5%	32,412 $352,000
Q3 2020 Nov 16, 2020	SELL	$7.59 - $10.8 $70,488 - $100,299	-9,287 Reduced 23.04%	31,015 $301,000
Q2 2020 Aug 17, 2020	BUY	$7.96 - $11.54 $189,455 - $274,663	23,801 Added 144.24%	40,302 $321,000
Q1 2020 May 15, 2020	BUY	$7.69 - $11.68 $126,892 - $192,731	16,501 New	16,501 $143,000
Q4 2019 Feb 14, 2020	SELL	$9.09 - $11.89 $180,491 - $236,087	-19,856 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$9.66 - $12.36 $21,319 - $27,278	2,207 Added 12.5%	19,856 $216,000
Q2 2019 Aug 14, 2019	BUY	$9.32 - $12.98 $164,488 - $229,084	17,649 New	17,649 $165,000

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.